Feb 13, 2017 12:05 pm UTC| Business
VY-SOD101 Selected Based on Robust Delivery and Knock-Down of Toxic SOD1 in Preclinical Models Program On Track for IND filing during 4Q:17 CAMBRIDGE, Mass., Feb. 13, 2017 -- Voyager Therapeutics, Inc....
Evogene Fourth Quarter and Full Year 2016 Earnings Announcement Schedule
Feb 13, 2017 12:02 pm UTC| Business
REHOVOT, Israel, Feb. 13, 2017 -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company for the improvement of crop productivity, announced today that it will release its financial results for the...
Nokia lays key 5G foundation with world's first 5GTF connection
Feb 13, 2017 12:02 pm UTC| Business
Press Release Telecom industry's first connection made conforming to 5GTF interface the industry-agreed specification for 'pre-standard' 5G applications, marking major milestone towards 3GPP NR Trial done in Oulu,...
Nokia lays key 5G foundation with world's first 5GTF connection
Feb 13, 2017 12:02 pm UTC| Business
Press Release Telecom industry's first connection made conforming to 5GTF interface the industry-agreed specification for 'pre-standard' 5G applications, marking major milestone towards 3GPP NR Trial done in Oulu,...
Pluristem Reports Second Quarter Fiscal 2017 Highlights & Provides Calendar 2017 Outlook
Feb 13, 2017 12:02 pm UTC| Business
HAIFA, Israel, Feb. 13, 2017 -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today reported financial update and corporate and clinical developments...
Pluristem Reports Second Quarter Fiscal 2017 Highlights & Provides Calendar 2017 Outlook
Feb 13, 2017 12:02 pm UTC| Business
HAIFA, Israel, Feb. 13, 2017 -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today reported financial update and corporate and clinical developments...
Pluristem Reports Second Quarter Fiscal 2017 Highlights & Provides Calendar 2017 Outlook
Feb 13, 2017 12:02 pm UTC| Business
HAIFA, Israel, Feb. 13, 2017 -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today reported financial update and corporate and clinical developments...
Electricity from farm waste: how biogas could help Malawians with no power
What the Supreme Court is doing right in considering Trump’s immunity case
US election: why it’s not the protesters’ votes that the Democrats should worry about
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects